微创颅内血肿清除术治疗高血压性脑出血疗效分析(1)
摘 要： 目的 探究微创颅内血肿清除术治疗高血压性脑出血疗效。 方法 将我院2016年3月～2017年3月收治的82例高血压脑出血患者，随机分为对照组与实验组，每组41例，对照组行传统手术治疗，实验组行微创颅内血肿清除术，比较两组治疗效果并分别于治疗前、治疗2周后记录两组血肿、水肿体积，NIHSS评分、观察治疗效果。 结果 实验组治疗有效率85.36%高于对照组51.22%，差异有统计学意义(P<0.05)；治疗2周后实验组血肿体积、水肿体积、NIHSS评分指标低于对照组，存在统计学差异(P<0.05)。结论 相比于传统手术而言，微创颅内血肿清除术手可有效降低手术对患者带来的侵入性伤害，可提高治疗效果，值得临床推广。
关键词：微创颅内血肿清除术；高血压性脑出血；血肿；水肿
中图分类号：R651.12 文献标识码：A DOI：10.3969/j.issn.1006-1959.2018.04.031
, 百拇医药
文章编号：1006-1959(2018)04-0095-03
Abstract：Objective To explore the therapeutic effect of minimally invasive intracranial hematoma removal for hypertensive cerebral hemorrhage.Methods In our hospital in March 2016～2017 year in March were 82 cases of patients with hypertensive cerebral hemorrhage were randomly divided into control group and experimental group，41 cases in each group， the control group underwent conventional surgical treatment，the experimental group underwent minimally invasive intracranial hematoma.The curative effect was compared between two groups and respectively before treatment，treatment after 2 weeks of record two hematoma and edema volume， NIHSS score，curative effect.Results The effective rate of the experimental group was 85.36%，which was higher than that of the control group 51.22%.The difference was statistically significant(P<0.05).After 2 weeks of treatment，the hematoma volume，edema volume and NIHSS score of the experimental group were lower than those of the control group，there were statistical differences(P<0.05).Conclusion Compared with traditional surgery，minimally invasive evacuation of intracranial hematoma can effectively reduce invasive injury caused by operation，and it can improve the therapeutic effect，and is worthy of clinical promotion.
, 百拇医药
Key words：Minimally invasive intracranial hematoma removal；Hypertensive intracerebral hemorrhage；Hematoma；Edema
高血压性脑出血(hypertensivecerebralhemorrhage)是长期高血压导致脑血管破裂造成，血液进入脑实质后堵塞脑脊液，引发脑积水与颅内压升高，随着血肿体积的增大，易对周边脑组织造成压迫，损伤神经功能，患者即刻出现头晕头痛、恶心呕吐、肢体偏瘫、意识障碍等症状，致残致死率极高[1]。尽快清除脑内血肿是治疗高血压性脑出血的有效方法，但传统内科治疗仅能进行简单的病情控制，清除颅内血肿速度缓慢，不能应对高血压性脑出血迅速变化的病情发展，而開颅手术创伤大、危险性高，许多患者并不敢冒险尝试，随着微创技术的成熟化发展，许多外科手术中均纷纷引入微创术治疗[2]。为研究我院2016年3月～2017年3月收治的82例高血压脑出血患者行微创颅内清除术的治疗效果，现分析如下。
, 百拇医药
1资料与方法
1.1 一般资料 将我院2016年3月～2017年3月收治的82例高血压脑出血患者纳为研究对象，本研究经医院伦理委员会批准。所有患者符合全国第四届脑血管会议[3]中有关高血压脑出血标准，均经头颅CT证实，病发至住院时间30 min～10 h，患者及家属知情并签署同意书；排除重要器官不全者、血管畸形者、凝血功能障碍者、心肺慢性疾病者与重要资料不全者。随机将其分为对照组与实验组，各41例，其中对照组男性24例，女性17例，年龄36～75岁，平均年龄(63.10±5.11)岁，基底节区出血15例，脑叶出血13例，小脑出血13例，浅昏迷19例，中度昏迷13例，深昏迷9例；实验组男23例，女18例，年龄37～77岁，平均年龄(62.25±4.36)岁，基底节区出血16例，脑叶出血15例，小脑出血10例，浅昏迷21例，中度昏迷12例，深昏迷8例；两组患者性别、年龄，疾病类型资料对比，差异无统计学意义(P>0.05)，具有可比性。, 百拇医药(尚凡军)
关键词：微创颅内血肿清除术；高血压性脑出血；血肿；水肿
中图分类号：R651.12 文献标识码：A DOI：10.3969/j.issn.1006-1959.2018.04.031
, 百拇医药
文章编号：1006-1959(2018)04-0095-03
Abstract：Objective To explore the therapeutic effect of minimally invasive intracranial hematoma removal for hypertensive cerebral hemorrhage.Methods In our hospital in March 2016～2017 year in March were 82 cases of patients with hypertensive cerebral hemorrhage were randomly divided into control group and experimental group，41 cases in each group， the control group underwent conventional surgical treatment，the experimental group underwent minimally invasive intracranial hematoma.The curative effect was compared between two groups and respectively before treatment，treatment after 2 weeks of record two hematoma and edema volume， NIHSS score，curative effect.Results The effective rate of the experimental group was 85.36%，which was higher than that of the control group 51.22%.The difference was statistically significant(P<0.05).After 2 weeks of treatment，the hematoma volume，edema volume and NIHSS score of the experimental group were lower than those of the control group，there were statistical differences(P<0.05).Conclusion Compared with traditional surgery，minimally invasive evacuation of intracranial hematoma can effectively reduce invasive injury caused by operation，and it can improve the therapeutic effect，and is worthy of clinical promotion.
, 百拇医药
Key words：Minimally invasive intracranial hematoma removal；Hypertensive intracerebral hemorrhage；Hematoma；Edema
高血压性脑出血(hypertensivecerebralhemorrhage)是长期高血压导致脑血管破裂造成，血液进入脑实质后堵塞脑脊液，引发脑积水与颅内压升高，随着血肿体积的增大，易对周边脑组织造成压迫，损伤神经功能，患者即刻出现头晕头痛、恶心呕吐、肢体偏瘫、意识障碍等症状，致残致死率极高[1]。尽快清除脑内血肿是治疗高血压性脑出血的有效方法，但传统内科治疗仅能进行简单的病情控制，清除颅内血肿速度缓慢，不能应对高血压性脑出血迅速变化的病情发展，而開颅手术创伤大、危险性高，许多患者并不敢冒险尝试，随着微创技术的成熟化发展，许多外科手术中均纷纷引入微创术治疗[2]。为研究我院2016年3月～2017年3月收治的82例高血压脑出血患者行微创颅内清除术的治疗效果，现分析如下。
, 百拇医药
1资料与方法
1.1 一般资料 将我院2016年3月～2017年3月收治的82例高血压脑出血患者纳为研究对象，本研究经医院伦理委员会批准。所有患者符合全国第四届脑血管会议[3]中有关高血压脑出血标准，均经头颅CT证实，病发至住院时间30 min～10 h，患者及家属知情并签署同意书；排除重要器官不全者、血管畸形者、凝血功能障碍者、心肺慢性疾病者与重要资料不全者。随机将其分为对照组与实验组，各41例，其中对照组男性24例，女性17例，年龄36～75岁，平均年龄(63.10±5.11)岁，基底节区出血15例，脑叶出血13例，小脑出血13例，浅昏迷19例，中度昏迷13例，深昏迷9例；实验组男23例，女18例，年龄37～77岁，平均年龄(62.25±4.36)岁，基底节区出血16例，脑叶出血15例，小脑出血10例，浅昏迷21例，中度昏迷12例，深昏迷8例；两组患者性别、年龄，疾病类型资料对比，差异无统计学意义(P>0.05)，具有可比性。, 百拇医药(尚凡军)